What are the cutaneous manifestations of Pseudomonas aeruginosa bacteremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cutaneous Manifestations of Pseudomonas Bacteremia

The hallmark cutaneous manifestation of Pseudomonas aeruginosa bacteremia is ecthyma gangrenosum, which presents as painless erythematous papules that rapidly progress to painful necrotic lesions within 24 hours, typically located between the umbilicus and knees 1.

Primary Skin Manifestations

Ecthyma Gangrenosum (Most Classic)

  • Pathophysiology: Cutaneous vasculitis caused by bacterial invasion of the media and adventitia of vessel walls, visible on histologic examination 1
  • Clinical presentation:
    • Begins as painless erythematous papule(s)
    • Rapidly becomes painful and necrotic within 24 hours
    • Lesions may be discrete or multiple
    • Preferentially located between umbilicus and knees
    • Can enlarge from 1 cm to >10 cm in <24 hours 1
  • Key caveat: While classically associated with P. aeruginosa, similar lesions can be caused by other Pseudomonas species, Aeromonas, Serratia, S. aureus, Stenotrophomonas maltophilia, fungi (Candida, Aspergillus, Mucor, Fusarium), and even HSV 1

Subcutaneous Nodules

  • Represent hematogenous seeding in bacteremic patients 2
  • Critical diagnostic feature: The organism can be visualized and cultured directly from biopsy of these nodules, allowing early targeted therapy 3
  • Occur primarily in immunocompromised hosts 2

Other Dermatologic Manifestations

The spectrum includes 1:

  • Erythematous maculopapular lesions
  • Focal or progressive cellulitis
  • Cutaneous nodules
  • Necrotizing fasciitis (occasionally)
  • Myonecrosis (occasionally)

High-Risk Context

Important distinction: In neutropenic/immunocompromised patients, necrotizing fasciitis and myonecrosis are more frequently associated with gram-negative or polymicrobial pathogens rather than single gram-positive bacteria 1. These can present alone or concurrently and may progress rapidly.

Clinical Recognition Pearls

Look for these characteristic features 4, 2:

  • Greenish discoloration of lesions
  • Distinctive odor
  • Rapid progression (within 24 hours)
  • Systemic manifestations: fever (100%), pain (88.9%), asthenia/adynamia (22.2%) 5

Diagnostic Approach

Obtain tissue diagnosis urgently: Combine blood cultures with biopsy or aspiration of abnormal skin lesions to increase pathogen recovery and direct pathogen-specific therapy 1. This is particularly critical because fever and pain with rapidly evolving necrotic lesions should prompt immediate empiric treatment pending culture results 5.

Management Implications

For suspected P. aeruginosa bacteremia with cutaneous manifestations, initiate broad-spectrum antipseudomonal antibiotics immediately 1:

  • Vancomycin PLUS antipseudomonal agent (cefepime, carbapenem [meropenem, imipenem-cilastatin, doripenem], or piperacillin-tazobactam)
  • Duration: 7-14 days for most bacterial SSTIs 1
  • Surgical intervention required for progressive necrotizing fasciitis/myonecrosis 1

Critical pitfall: The growing antimicrobial resistance of P. aeruginosa poses significant therapeutic challenges 4. Early recognition through characteristic cutaneous manifestations is critical for successful management of potentially life-threatening disease 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.